Farallon Capital Management 13F holdings, Q2 2020
Holdings as of June 30, 2020 · filings on SEC EDGAR · latest filing →
Farallon Capital Management disclosed 117 US equity positions worth $12.4bn in its Q2 2020 13F filing. The largest position was IQV at 4.3% of the reported book, followed by FIS and IAC INTERACTIVECORP. Against the Q1 2020 filing, it opened 9 new positions, added to 16 and reduced 20 among the top 50 holdings.
What did Farallon Capital Management own in Q2 2020? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2020 |
|---|---|---|---|---|---|---|---|
| 1 | IQV IQVIA HLDGS INC | Healthcare | 4.3% | $538.6m | 3,796,030 | 2% | added |
| 2 | FIS FIDELITY NATL INFORMATION SV | Technology | 3.9% | $481.4m | 3,590,128 | -22% | reduced |
| 3 | IAC INTERACTIVECORP | 3.7% | $456.0m | 1,410,000 | -18% | reduced | |
| 4 | CNC CENTENE CORP DEL | Healthcare | 3.6% | $444.9m | 7,000,000 | -3% | reduced |
| 5 | ABBV ABBVIE INC | Healthcare | 3.3% | $407.4m | 4,150,000 | 4% | added |
| 6 | TMO THERMO FISHER SCIENTIFIC INC | Healthcare | 3.1% | $387.5m | 1,069,505 | -14% | reduced |
| 7 | CHTR CHARTER COMMUNICATIONS INC N | Communication Services | 3.1% | $385.1m | 755,015 | 4% | added |
| 8 | TMUS T-MOBILE US INC | Communication Services | 2.9% | $360.1m | 3,457,631 | – | new |
| 9 | V VISA INC | Financial Services | 2.8% | $347.6m | 1,799,373 | 2% | added |
| 10 | AON AON PLC | Financial Services | 2.7% | $331.4m | 1,720,498 | – | new |
| 11 | ELV ANTHEM INC | Healthcare | 2.6% | $328.7m | 1,250,000 | 0% | held |
| 12 | GOOG ALPHABET INC | Communication Services | 2.5% | $312.5m | 221,050 | -25% | reduced |
| 13 | MSFT MICROSOFT CORP | Technology | 2.5% | $311.0m | 1,528,199 | -16% | reduced |
| 14 | META FACEBOOK INC | Communication Services | 2.5% | $308.5m | 1,358,494 | 25% | added |
| 15 | IHS MARKIT LTD | 2.4% | $295.2m | 3,910,024 | -21% | reduced | |
| 16 | CRM SALESFORCE COM INC | Technology | 2.3% | $285.8m | 1,525,648 | -6% | reduced |
| 17 | 58 COM INC | 2.2% | $267.8m | 4,965,212 | – | new | |
| 18 | SHW SHERWIN WILLIAMS CO | Basic Materials | 2.1% | $258.9m | 447,987 | -12% | reduced |
| 19 | WAB WABTEC | Industrials | 2.0% | $249.0m | 4,325,361 | -32% | reduced |
| 20 | EXEL EXELIXIS INC | Healthcare | 2.0% | $243.3m | 10,250,000 | 2% | added |
| 21 | BMY BRISTOL-MYERS SQUIBB CO | Healthcare | 1.7% | $213.2m | 3,625,000 | – | new |
| 22 | XLRN ACCELERON PHARMA INC | 1.6% | $200.1m | 2,100,000 | -3% | reduced | |
| 23 | BABA ALIBABA GROUP HLDG LTD | Consumer Cyclical | 1.6% | $199.9m | 926,700 | -18% | reduced |
| 24 | PANW PALO ALTO NETWORKS INC | Technology | 1.6% | $195.7m | 852,105 | -14% | reduced |
| 25 | EQIX EQUINIX INC | Real Estate | 1.5% | $187.9m | 267,597 | -5% | reduced |
| 26 | TIFFANY & CO NEW | 1.5% | $186.3m | 1,527,698 | – | new | |
| 27 | IOVA IOVANCE BIOTHERAPEUTICS INC | Healthcare | 1.4% | $179.5m | 6,537,500 | 14% | added |
| 28 | NYT NEW YORK TIMES CO | Communication Services | 1.4% | $173.9m | 4,137,542 | – | new |
| 29 | GD GENERAL DYNAMICS CORP | Industrials | 1.4% | $172.1m | 1,151,481 | -45% | reduced |
| 30 | ASND ASCENDIS PHARMA A S | Healthcare | 1.4% | $168.6m | 1,140,000 | -17% | reduced |
| 31 | BRISTOL-MYERS SQUIBB CO | 1.3% | $158.2m | 44,200,000 | 26% | added | |
| 32 | BX BLACKSTONE GROUP INC | Financial Services | 1.3% | $156.9m | 2,768,319 | 587% | added |
| 33 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 1.2% | $155.5m | 1,050,000 | -30% | reduced |
| 34 | QGEN QIAGEN NV | Healthcare | 1.0% | $123.3m | 2,881,000 | -3% | reduced |
| 35 | WRIGHT MED GROUP N V | 1.0% | $121.9m | 4,100,000 | 80% | added | |
| 36 | FATE FATE THERAPEUTICS INC | Healthcare | 1.0% | $120.1m | 3,500,000 | 17% | added |
| 37 | PLAYA HOTELS & RESORTS NV | 0.9% | $110.8m | 30,606,930 | 0% | held | |
| 38 | TRU TRANSUNION | Financial Services | 0.8% | $103.8m | 1,192,747 | -41% | reduced |
| 39 | CAESARS ENTMT CORP | 0.8% | $97.2m | 8,015,000 | – | new | |
| 40 | CI CIGNA CORP NEW | Healthcare | 0.8% | $93.8m | 500,000 | -60% | reduced |
| 41 | ENTA ENANTA PHARMACEUTICALS INC | Healthcare | 0.7% | $87.9m | 1,750,000 | 0% | held |
| 42 | MYOKARDIA INC | 0.7% | $84.5m | 875,000 | 103% | added | |
| 43 | SRPT SAREPTA THERAPEUTICS INC | Healthcare | 0.7% | $84.2m | 525,000 | 50% | added |
| 44 | NEW ORIENTAL ED & TECHNOLOGY | 0.7% | $82.2m | 631,000 | – | new | |
| 45 | MIRATI THERAPEUTICS INC | 0.6% | $74.2m | 650,000 | 8% | added | |
| 46 | APELLIS PHARMACEUTICALS INC | 0.6% | $73.5m | 2,250,000 | 12% | added | |
| 47 | BROADMARK RLTY CAP INC | 0.5% | $67.9m | 7,170,213 | 0% | held | |
| 48 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 0.5% | $66.8m | 1,250,000 | 0% | held |
| 49 | FIBROGEN INC | 0.5% | $65.9m | 1,625,000 | 2% | added | |
| 50 | MOMO INC | 0.5% | $64.2m | 81,601,000 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.